COVID-19: Update from PharPoint Research

As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted.

During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health.

Our leadership team has been closely monitoring the situation since the initial outbreak and have proper risk mitigation strategies in place. These include, work from home protocols for our fully-trained staff, contingency plans in the event of any physical office or site closures, and a review of our communication practices to ensure continuous support.

PharPoint Research has long maintained robust work remote capabilities and processes. In the event of office closures, there will be minimal disruptions to ensure continuous business operations.

PharPoint Research will continue to support clients to our same high standards throughout this time.

Both the continued support of our client’s invaluable work in improving the lives of patients and the safety of our employees are top priorities.

Together, we can overcome these challenging times.